Effects of Serum Amyloid A and Lysophosphatidylcholine on Intracellular Calcium Concentration in Human Coronary Artery Smooth Muscle Cells

この論文をさがす

抄録

Serum amyloid A (SAA), an acute-phase protein, and lysophosphatidylcholine (LPC), an oxidized LDL component, contribute to the physiological processes of atherosclerosis and cardiovascular disease. However, the effects of SAA/LPC on human coronary artery smooth muscle cells (hCASMCs) have not been fully investigated. Therefore, we examined the effects of SAA/LPC on Ca2+/Mg2+ mobilization and its underlying mechanisms in hCASMCs. Intracellular Ca2+/Mg2+ concentration ([Ca2+]i / [Mg2+]i) was measured with fura-2 AM/mag-fura-2 AM. Conventional RT-PCR analysis was also performed. Both SAA and LPC increased [Ca2+]i by Ca2+ entry. The SAA-induced Ca2+ entry was inhibited by Gd3+, SKF96365, and 2-aminoethoxydiphenyl borate (2-APB), a nonselective transient receptor potential (TRP) channel blocker, but not nifedipine. The LPC-induced Ca2+ entry was blocked by Gd3+, but not nifedipine, SKF96365 and 2-APB. U-73122 and PTX prevented the activation of SAA-, but not LPC-induced Ca2+ influx. LPC, but not SAA, increased [Mg2+]i as well as [Ca2+]i. The RT-PCR analysis revealed the expression of TRPC1/4, TRPV1/2/4, and TRPM7/8 mRNA. These results suggest that SAA/LPC activate Ca2+ influx in hCASMCs; SAA activates it via PTX-sensitive G-protein, PLC and TRPC pathways, while LPC activates it independently of these pathways, where TRPM7 may be partly involved. Thus, TRP protein appears to be a target molecule of Ca2+ signaling in hCASMCs elicited by SAA/LPC, which may play roles in coronary muscle dysfunction under pathophysiological and inflammatory conditions such as atherosclerosis.

収録刊行物

  • International Heart Journal

    International Heart Journal 52 (3), 185-193, 2011

    一般社団法人 インターナショナル・ハート・ジャーナル刊行会

被引用文献 (1)*注記

もっと見る

参考文献 (64)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ